The effect of dGuo -being the toxic metabolite in PNPDiv. of Clinical Biochemistry, Vienna, Austria deficiency -on normal B lymphocytes was studied: purified B cells were cultured with formalinized Staphylococcus aureus Cowan I during 18 hours, leading to activation of resting B cells which then become sensitive to the action of B cell growth and differentiation factors present in the supernatant of Con-Aactivated T cells. In this system both proliferation and differentiation of the B cells do occur and can be inhibited by dGuo in a dose-dependent way. Subsequently the mechanism of this inhibitory phenomenon was studied, e.g. by addition of hypoxanthine, adenine, deoxycytidine and the PNP-inhibitor 8-aminoguanosine. The results indicate that the accumulation of dGTP is not the cause of dGuo toxicity for in vitro function of normal -B cells. Toxicity of dGuo requires the presence of active PNP and most probably is based on a product of the salvage of guanine (i.e. GMP, GDP or GTP). We conclude that proliferation and differentiation of normal B cells is inhibited by dGuo through a mechanism independent of dGTP accumulation. Consequently B cells of PNP deficient patients escape dGuo toxicity because PNP is lacking.
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Since there is little information about the enzyme distribution of purine catabolism and salvage available, it was reasonable to determine activities of some key enzymes in human tissue samples. This might be of in~portance for purine metabolism of human muscle of different origin. Using radiochemical tests the following enzyme activities were detected: adenosine kinase (AK), adenine phopshoribosyltransferase (APRT), hypoxanthin guanine phosphoribosyltransferase (HGPRT), adenosine deaminase (ADA), and purinenucleoside phosphorylase (PNP).
The In earlier studies we showed that deoxvnuanosine(dGuo) which Div. of Clinical Biochemistry, Vienna, Austria . -confers immunodeficiency in purine nucleoside phosphorylase (PNP) deficient patients, inhibits the in vitro proliferation of normal human T and B lymphocytes. Deoxyadenosine (dAdo) being the toxic metabolite in adenosine deaminase (ADA) deficiency, also inhibits the in vitro proliferation of normal human T lymphocytes under conditions where ADA activity is inhibited. We analyzed the kinetics of the inhibition of T cell proliferation by dAdo and dGuo respectively and found significant differences. Whereas dAdo has to be present from the initiation of the culture onwards, dGuo can be added as late as 48 hrs. after the initiation of the culture to exert its toxic effect. This finding points towards an interference of dAdo with early lymphocyte activation events which preceed the onset of DNA synthesis. Subsequently, the effect of dAdo and dGuo on a number of events associated with lymphocyte activation was investigated like e.g. on mitogen-
The reutilization of purine bases and purine nuclebsides was investigated in rat heart myoblasts. The cells were cultivated in Eagle's medium. Incubations were performed at 37" for 1 hour,l4C-labeled adenine, hypoxanthine, adenosine and inosine were used as substrates (5.2 pmol/l). After the incubation cells were harvested, purine metabolites extracted with perchloric acid and separated by thin-layer chromatography. The radioactivity of metabolites was measured.
The total incorporation into rat heart myoblasts' purines was for adenine, hypoxanthine, adenosine Adenosine has been reported to attenuate the positive inotropic effects of catecholamines in in vitro-heart preparations of rodents. These results were not confined in anesthetized dogs during intracormary infusion of isoproterenol. However, these exprimmts did nat study the effects of adenosine on the inotropic effects of endcgemusly released catecholamines. Therefore we performed cardiac smthetic nerve stimulation (CSNS) i n 5 anesthetized, vagotanized dcgs. The left circumflex coronary artery was perfused at a constant pressure of 130k4 mnHg. The contractile function of the circumflex-perfused myocardim was analyzed by Soncpnic-try. CSNS at 1, 2, 5, 10 and 20 Hz increased systolic m t shortening (SS ) h a frequency-dependent m e r fran 10.9k2.6 at ccmtrolctb 15.3t3. The conventional treatment of those patients with gout in whom urate-lowering medication is considered desirable is to administer such drugs continuously for an indefinite period.
It has been shown that dissolution rates of urate crystals in normouricemic or hyperuricemic solutions in vitro are very fast compared with rates of crystal growth in supersaturated solutions. Our previous clinical studies have shown that after discontinuing treatment with allopurinol the serum uric acid level returns rapidly to pre-treatment values, but long periods may pass before the return of gouty arthritis. In the light of these observations it seems logical to assess the effect of intermittent control of hyperuricemia in the treatment of gout. ism in rcdents is a species dependent phencmenon.
Supported by SFB 30 -Kardiologie, Misseldorf
